Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine and cultured medium of cell cultures.
Exosome Diagnostic and Therapeutic Market contains market size and forecasts of Exosome Diagnostic and Therapeutic in Global, including the following market information:
- Global Exosome Diagnostic and Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Exosome Diagnostic and Therapeutic market was valued at 101.1 million in 2021 and is projected to reach US$ 760.6 million by 2028, at a CAGR of 33.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instrument Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Exosome Diagnostic and Therapeutic include AMS Biotechnology, ReNeuron, ExoCyte Therapeutics, Cell Guidance Systems, BioRegenerative Sciences and Norgen Biotek, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Exosome Diagnostic and Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Exosome Diagnostic and Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Exosome Diagnostic and Therapeutic Market Segment Percentages, by Type, 2021 (%)
- Instrument
- Reagent
- Software
Global Exosome Diagnostic and Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Exosome Diagnostic and Therapeutic Market Segment Percentages, by Application, 2021 (%)
- Cancer Institute
- Hospital
- Diagnostic Center
- Others
Global Exosome Diagnostic and Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Exosome Diagnostic and Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Exosome Diagnostic and Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Exosome Diagnostic and Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AMS Biotechnology
- ReNeuron
- ExoCyte Therapeutics
- Cell Guidance Systems
- BioRegenerative Sciences
- Norgen Biotek
Industry Market Size
